Viral Vectors and Virus-Like Particles Symposium
This symposium brings together scientists from Umeå University to exchange knowledge on advancements in the field of viral vectors and virus-like particles. Five invited keynote speakers will discuss virus vectors and virus-like particles ranging from research tool to clinical applications in cancer treatment, gene therapy, and immunization. In addition, you are invited to present your research in a short talk or poster presentation. This event is free of charge thanks to the generous contribution of Umeå Centre for Microbial Research (UCMR) and the Umeå University Faculty of Medicine.
Reserve your spot now—space is limited!
Register and hand in your abstract (max 500 words) via the registration link above before the 15th of August 2024.
Time and location
12 September 2024, 08:30 – 17:00
Bergasalen, Norrlands Universitetssjukhus, Umeå, Sweden
Questions?
Contact Tessy Hick (tessy.hick@umu.se).
Keynote speakers
Thomas Hoenen - Friedrich Loeffler Institute, Germany
Studying highly pathogenic viruses with transcription and replication-competent virus-like particles and other reverse genetics systems
Giuditta De Lorenzo - AREA Science Park, Italy
Pre-clinical evaluation of an engineered VLP-based vaccine candidate against ZIKV
Christin Schmidt - TRON Translational Oncology, Germany
Trans-amplifying RNA as vaccine platform and its use as chikungunya virus vaccine
Niklas Arnsberg - Umeå University
Virus-receptor interactions: Implications for vector targeting and adenovirus as a model.
Ya-Fang Mei - Umeå University
Molecular bases and recent advances of the oncolytic adenovirus
11p vectors in cancer therapy
About the organizers
The organizers, Malgorzata Graul and Tessy Hick, are both postdocs at Department of Clinical Microbiology at Umeå University, Sweden.
Malgorzata (Gosia) studies the differences in host cell membrane interactions of filoviruses using transcription and replication competent virus-like particles carrying filovirus glycoproteins.
Tessy studies alphavirus host-protein interactions, but has a great interest in viral vectors by her previous research on alphavirus replicon vaccines, AAV vectors for gene therapy, and baculovirus-expression systems.